MedPath
NMPA Approval

Isepamicin Sulfate Injection

国药准字H20249397

November 15, 2024

Drug Information

硫酸异帕米星注射液

注射剂

2ml: 0.2g(按C₂₂H₄₃N₅O₁₂计)

化学药品

November 15, 2024

Company Information

Applicant Company

北京市北京经济技术开发区永昌中路5号

Manufacturing Company

重庆市渝北区人和镇星光大道100号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硫酸异帕米星注射液 - NMPA 批准文号 | MedPath